BioCentury
ARTICLE | Company News

Management tracks: G1, Collegium, Nimbus

July 10, 2018 9:57 PM UTC

Cancer company G1 Therapeutics Inc. (NASDAQ:GTHX) hired John Demaree as chief commercial officer and Stillman Hanson as general counsel. Demaree was VP of oncology marketing at Astellas Pharma Inc. (Tokyo:4503). Hanson was associate general counsel and VP at Quintiles Transnational Holdings Inc., which is now part of IQVia Holdings Inc. (NYSE:IQV).

Pain company Collegium Pharmaceutical Inc. (NASDAQ:COLL) promoted Scott Dreyer to EVP and COO from SVP of sales, marketing and training...